Residential Psychiatric Treatment for Young Adults in New England?
Question by CQ: Residential psychiatric treatment for young adults in New England?
Treatment needed for an 18 year old suicidal girl with PTSD, anorexia/bulimia, drug and alcohol abuse, self-harm, depression, severe anxiety, and possibly borderline personality disorder.
Any suggestions of centers or hospitals in the Northeast, preferably in Massachusetts but not necessarily?
Thank you SO MUCH.
Yes, this is one girl, and she HAS been diagnosed with all of these things. The “possible BPD” is because one doctor thinks she has it and one thinks she doesn’t.
Best answer:
Answer by Dancie
you’re going to need a lot of separate treatment places for so many different people… oh wait, just one girl? First, stop self-diagnosing a condition you know nothing about, and go to a REAL psychologist. They will determine whether you need residential treatment, and where is best for you to go. It isn’t a spa, you dn’t exactly just show up with a robe and sunscreen.
What do you think? Answer below!
Holiday book gift ideas from UC Davis authors: Snow White, bats, hip-hop and …
Filed under: residential drug treatment centers
“Annals of the Omega Project — A Trilogy,” by Thomas A. Cahill (EditPros LLC, $ 19.95, 354 pages) — A UC Davis physicist most recently known for his work analyzing pollutants at Ground Zero of the World Trade Center post 9/11 pens his first fiction …
Read more on UC Davis
Chronic hepatitis C: new cause for optimism
Filed under: residential drug treatment centers
Amid this bad news, however, is emerging a remarkably promising treatment picture, said Dr. Marc Ghany of the liver diseases branch at the National Institute of Diabetes and Digestive and Kidney Diseases n Bethesda, Md. At grand rounds at the NIH …
Read more on Family Practice News Digital Network
Sucampo Shares Rise on FDA Approval of Glaucoma Treatment
Filed under: residential drug treatment centers
Sucampo Pharmaceuticals Inc. (SCMP) is rising in value Wednesday morning on news that the Food and Drug Administration has approved the company's supplemental new drug application for Rescula solution (unoprostone isopropyl), a treatment to lower …
Read more on Equities.com